p38 Mitogen-Activated Protein Kinase Is Activated and Linked to TNF-α Signaling in Inflammatory Bowel Disease1
暂无分享,去创建一个
Philip Rosenstiel | Stefan Schreiber | S. Schreiber | P. Rosenstiel | D. Seegert | S. Nikolaus | G. H. Waetzig | Susanna Nikolaus | Georg H. Waetzig | Dirk Seegert | S. Schreiber
[1] S. Nikolaus,et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation , 1998, Gut.
[2] S. Deventer,et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease , 2002, Gut.
[3] L. Mahadevan,et al. Combinations of ERK and p38 MAPK Inhibitors Ablate Tumor Necrosis Factor-α (TNF-α) mRNA Induction , 2001, The Journal of Biological Chemistry.
[4] Ami,et al. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.
[5] John C. Lee,et al. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms , 1996, Journal of leukocyte biology.
[6] S. Targan,et al. Tumor necrosis factor: biology and therapeutic inhibitors. , 2000, Gastroenterology.
[7] A. Arrigo. Expression and function of the low-molecular-weight heat shock proteins , 1994 .
[8] P. Cohen,et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.
[9] M. Cobb,et al. Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.
[10] W Domschke,et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. , 2001, Gastroenterology.
[11] S. Targan,et al. Role of cytokines in the pathogenesis of inflammatory bowel disease. , 2000, Annual review of medicine.
[12] P. Rosenstiel,et al. Increased expression of IL-16 in inflammatory bowel disease , 2001, Gut.
[13] C. Ferran,et al. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. , 1994, The Journal of clinical investigation.
[14] U. Rapp,et al. Different Mitogen-activated Protein Kinase Signaling Pathways Cooperate to Regulate Tumor Necrosis Factor α Gene Expression in T Lymphocytes* , 1999, The Journal of Biological Chemistry.
[15] J. Hampe,et al. Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease , 1999, The Lancet.
[16] J. Lennard-jones,et al. Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.
[17] J. Woodgett,et al. The stress-activated protein kinase pathways , 1999, Cellular and Molecular Life Sciences CMLS.
[18] D. Hommes,et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. , 2002, Gastroenterology.
[19] Shigeru Tsuchiya,et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.
[20] Jean Weissenbach,et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.
[21] D. Podolsky,et al. Inflammatory bowel disease (1) , 1991, The New England journal of medicine.
[22] S. Nedospasov,et al. Role of p52 (NF-kappaB2) in LPS Tolerance in a Human B Cell Line , 1999, Biological chemistry.
[23] J. A. Badwey,et al. Activation of p90RSK and cAMP response element binding protein in stimulated neutrophils: novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade. , 1999, Journal of immunology.
[24] S. Kassis,et al. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. , 1998, The Journal of pharmacology and experimental therapeutics.
[25] David Wallach,et al. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’ , 1999, The EMBO journal.
[26] C. Manthey,et al. Molecular Cloning and Characterization of a Novel p38 Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[27] G. Moore,et al. Production of Free Light Chains of Immunoglobulin by a Hematopoietic Cell Line Derived from a Patient with Multiple Myeloma.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[28] Richard I. Morimoto,et al. 1 Progress and Perspectives on the Biology of Heat Shock Proteins and Molecular Chaperones , 1994 .
[29] A. Hasebe,et al. The N-Terminal Lipopeptide of a 44-kDa Membrane-Bound Lipoprotein of Mycoplasma salivarium Is Responsible for the Expression of Intercellular Adhesion Molecule-1 on the Cell Surface of Normal Human Gingival Fibroblasts1 , 2000, The Journal of Immunology.
[30] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[31] S. Wright,et al. Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes. , 1997, Journal of immunology.
[32] S. Targan,et al. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .
[33] M. Feldmann,et al. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. , 1998, Journal of immunology.
[34] F. Breedveld,et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. , 1999, Journal of immunology.
[35] Takahiko Horiuchi,et al. Outside-to-Inside Signal Through the Membrane TNF-α Induces E-Selectin (CD62E) Expression on Activated Human CD4+ T Cells1 , 2001, The Journal of Immunology.
[36] T. Hunter,et al. p38-2, a Novel Mitogen-activated Protein Kinase with Distinct Properties* , 1997, The Journal of Biological Chemistry.
[37] R. Macdermott,et al. Enhand secretion of tumour necrosis factor‐alpha, IL‐6, and IL‐1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease , 1993 .
[38] I. Bjarnason,et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. , 2000, Gastroenterology.
[39] S. Krautwald. IL-16 activates the SAPK signaling pathway in CD4+ macrophages. , 1998, Journal of immunology.
[40] P. Rutgeerts,et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.
[41] J. Landry,et al. 14 Expression and Function of the Low-molecular-weight Heat Shock Proteins , 1994 .
[42] C. Widmann,et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. , 1999, Physiological reviews.
[43] P. Grebe,et al. Image of the month. Defective belch reflex secondary to achalasia. , 2002, Gastroenterology.
[44] S. Schreiber,et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. , 1993, Clinical and experimental immunology.
[45] J. Telliez,et al. Engagement of Tumor Necrosis Factor (TNF) Receptor 1 Leads to ATF-2- and p38 Mitogen-activated Protein Kinase-dependent TNF-α Gene Expression* , 1999, The Journal of Biological Chemistry.
[46] S. Nikolaus,et al. Mechanisms in failure of infliximab for Crohn's disease , 2000, The Lancet.
[47] G. Bornkamm,et al. Characterization of EBV‐genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non‐Hodgkin lymphoma , 1977, International journal of cancer.
[48] T. Macdonald,et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. , 1993, Gut.
[49] T. Gray,et al. Expression and functions of purinergic receptor P2X7 in colonic macrophages and T lymphocytes from normal and inflammatory bowel disease mucosa , 2001 .
[50] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[51] C. Y. Wang,et al. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody , 1988, The Journal of experimental medicine.
[52] Y. Ip,et al. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.
[53] P. Desreumaux,et al. Enhanced production of IL‐8 in chronic but not in early ileal lesions of Crohn's disease (CD) , 2000, Clinical and experimental immunology.
[54] D E Griswold,et al. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. , 1996, The Journal of pharmacology and experimental therapeutics.
[55] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[56] N J Lynch,et al. Linkage of inflammatory bowel disease to human chromosome 6p. , 1999, American journal of human genetics.
[57] A. Ullrich,et al. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] C. Manthey,et al. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. , 1999, Journal of immunology.
[59] R. Sundler,et al. Signalling to translational activation of tumour necrosis factor-alpha expression in human THP-1 cells. , 2000, Cytokine.
[60] K. M. Rao. MAP kinase activation in macrophages , 2001, Journal of leukocyte biology.
[61] G. Kollias,et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.
[62] S. Roy,et al. ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ* , 2001, The Journal of Biological Chemistry.